Gliosarcoma: An immunohistochemical, ultrastructural and fluorescence in situ hybridization study

Pathology International

Volumn 48, Issue 8, 1998, Pages 595-602

  Horiguchi, Hidehisa ^a   Hirose, Takanori ^a   Kannuki, Seiji ^a   Nagahiro, Shinji ^a   Sano, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Fluorescence in situ hybridization; Gliosarcoma; MIB 1; P53 protein

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 10; CHROMOSOME 17; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROUGH ENDOPLASMIC RETICULUM; ULTRASTRUCTURE;

EID: 0031684719     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03956.x     Document Type: Article

References (36)

1. Kleihus P, Burger PC, Scheithauer BW. Histological Typing of the Central Nervous System, 2nd edn. Springer-Verlag, Berlin, 1993.
2. Burger PC, Sheithauer BW, eds. Tumors of the Central Nervous System. Atlas of Tumor Pathology, Fascicle 10, Series 3. Armed Forces Institute of Pathology, Washington DC, 1994.
3. Meis JM, Martz KL, Nelson JS. Mixed glioblastoma multiforme and sarcoma: A clinicopathologic study of 26 radiation therapy oncology group cases. Cancer 1991; 67: 2342-2349.
4. Haddad SF, Moore SA, Schelper RL, Goeken JA. Smooth muscle can compromise the sarcomatous component of gliosarcomas. J. Neuropathol. Exp. Neurol. 1992; 51: 493-498.
5. Kepes JJ, Bastian FO, Weber ED. Gliosarcoma developing from an irradiated ependymoma. Acta Neuropathol. 1996; 92: 515-519.
6. Kochi N, Budka H. Contribution of histiocytic cells to sarcomatous development of the gliosarcoma: An immunohistochemical study. Acta Neuropathol. 1987; 73: 124-130.
7. Ng HK, Poor WS. Gliosarcoma of the posterior fossa with features of a malignant fibrous histiocytoma. Cancer 1990; 65: 1161-1166.
8. Hayashi K, Ohara N, Ho JJ et al. Gliosarcoma with features of chondroblastic osteosarcoma. Cancer 1993; 72: 850-855.
9. Stapleton SR, Harkness W, Wilkins PR, Uttley D. Gliomyosarcoma: An immunohistochemical analysis. J. Neurol. Neurosurg. Psychiatry 1992; 55: 728-730.
10. Feigin IH, Ransohoff J, Lieberman A. Sarcoma arising in oligodendroglioma of the brain. J. Neuropathol. Exp. Neurol. 1976; 35: 679-684.
11. Schiffer D, Giordana MT, Mauro A, Migheli A. GFAP, FVIII/RAg, laminin and fibronectin in gliosarcomas: An immunohistochemical study. Acta Neuropathol. 1986; 63: 108-116.
12. Slowik F, Jellinger K, Gaszó L, Fischer J. Immunohistochemical, ultrastructural and tissue culture studies. Acta Neuropathol. 1985; 67: 201-210.
13. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki 67 immunoreactivity in human central nervous system tumors: A study with MIB1 monoclonal antibody on archival material. Acta Neuropathol. 1994; 87: 47-54.
14. Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol. 1993; 85: 316-322.
15. Karamitopoulou E, Perentes E, Diamantis I. p53 Protein expression in central nervous system tumors: An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol. 1993; 85: 611-616.
16. Hashimoto N, Ichikawa D, Arakawa Y et al. Frequent deletions of material from chromosome arm 1p in oligodendroglial tumors revealed by double-target fluorescence in situ hybridization and microsatellite analysis. Genes Chromosomes Cancer 1995; 14: 295-300.
17. Feigin IH, Gross SW. Sarcoma arising in glioblastoma of the brain. Am. J. Pathol. 1955; 31: 633-653.
18. Morantz RA, Feigin I, Ransohoff J. Clinical and pathological study of 24 cases of gliosarcoma. J. Neurosurg. 1976; 45: 398-408.
19. Perry JR, Ang LC, Bilbao JM, Mullar PJ. Clinicopathologic features of primary and post-irradiation cerebral gliosarcoma. Cancer 1995; 75: 2910-2918.
20. Parekh HC, O'Donovan DG, Sharma RR. Primary cerebral gliosarcoma: Report of 17 cases. Br. J. Neurosurg. 1995; 9: 171-178.
21. Carstens PHB, Johnson GS, Jelsma LF. Spinal gliosarcoma: A light, immunohistochemical and ultrastructural study. Ann. Clin. Lab. Sci. 1995; 25: 241-246.
22. Prayson RA, Estes M. MIB-1 and p53 immunoreactivity in protoplasmic astrocytoma. Pathol. Int. 1996; 46: 862-866.
23. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotny PJ, Jenkins RB. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value. J. Neurosurg. 1997; 86: 121-130.
24. Albrecht S, Conelly JH, Bruner JM. Distribution of p53 protein expression in gliosarcomas: An immunohistochemical study. Acta Neuropathol. 1993; 85: 222-226.
25. Banerjee AK, Sharma BS, Kak VK, Ghatak NR. Gliosarcoma with cartilage formation. Cancer 1989; 63: 518-523.
26. Eizaguirre B, Eizalde JM, Martinetz LJ, Ereno C, Lopez JI. Gliosarcoma: Case report with immunohistochemical study. Arch. Anal Cytol. Pathol. 1994; 42: 54-56.
27. Grant JW, Steart PV, Agguzzi A, Jones DB, Gallagher PJ. Gliosarcoma: An immunohistochemical study. Acta Neuropathol. 1989; 79: 305-309.
28. Meis JM, Ho KL, Nelson JM. Gliosarcoma: A histologic and immunohistochemical reaffirmation. Mod. Pathol. 1990; 3: 19-24.
29. Ho KL. Histogenesis of sarcomatous component of the gliosarcoma: An ultrastructural study. Acta Neuropathol. 1990; 81: 178-188.
30. Kishikawa M, Tsuda N, Fujii H, Nishimori I, Yokoyama H, Kihar M. Glioblastoma with sarcomatous component associated with myxoid change: A histochemical, immunohistochemical and electron microscopic study. Acta Neuropathol. 1986; 70: 44-52.
31. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. p53 Mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 1992; 52: 674-679.
32. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 1993; 3: 19-26.
33. Dalrymple SJ, Herath JF, Ritland SR, Moertel CA, Jenkins RB. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. J. Neurosurg. 1995; 83: 316-323.
34. Mollenhauser J, Wiemann S, Scheuren W et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat. Genet. 1997; 17: 32-39.
35. Paulus W, Bayas A, Ott G, Roggendorf W. Interphase cytogenetics of glioblastoma and gliosarcoma. Acta Neuropathol. 1994; 88: 420-425.
36. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J. Neuropathol. Exp. Neurol. 1995; 54: 651-656.